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A CBP Binding Transcriptional Repressor Produced
by the PS1/-Cleavage of N-Cadherin Is Inhibited
by PS1 FAD Mutations
erin/catenin cell adhesion complexes (Baki et al., 2001;
Georgakopoulos et al., 1999; Nowotny et al., 2000; Xia
et al., 2001). In the brain, PS1 forms complexes with
N-cadherin (Georgakopoulos et al., 1999), a type I trans-
membrane protein and a member of the classic cadherin
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family of Ca-dependent cell adhesion factors (Perez-Mount Sinai School of Medicine
Moreno et al., 2003). Both proteins are expressed inNew York, New York 10029
neurons and have been found at the synapse (Georgako-2 Laboratory of Alzheimer’s Disease
poulos et al., 1999; Uchida et al., 1996). N-cadherin ho-Institute of Physical and Chemical Research
mophilic interactions may play an important role in bind-2-1 Hirosawa, Wako
ing pre- and postsynaptic membranes together (FannonSaitama 351-0198
and Colman, 1996). Furthermore, N-cadherin promotesJapan
axonal outgrowth and regulates synaptogenesis and3 Department of Pharmacology
long-term potentiation (Goda, 2002; Huntley et al., 2002).University of Pennsylvania School of Medicine
PS1 is important for the -secretase cleavages of thePhiladelphia, Pennsylvania 19104
amyloid precursor protein (APP), which results in the
production of the A peptide of Alzheimer’s disease
(AD) (De Strooper et al., 1998). Recent reports, however,
show that in addition to the classic -secretase cleav-Summary
ages of APP defined by the C terminus of various A
species, the PS1/-secretase system promotes thePresenilin1 (PS1), a protein implicated in Alzheimer’s
-cleavage (Weidemann et al., 2002) of several type Idisease (AD), forms complexes with N-cadherin, a
transmembrane proteins, including APP, Notch1, E-cadh-transmembrane protein with important neuronal and
erin, and CD44. Although this cleavage is also sensitivesynaptic functions. Here, we show that a PS1-depen-
to -secretase inhibitors, it takes place further down-dent -secretase protease activity promotes an -like
stream from the amyloidogenic -secretase cleavagescleavage of N-cadherin to produce its intracellular do-
at a site closer to the membrane/cytoplasm interfacemain peptide, N-Cad/CTF2. NMDA receptor agonists
than the -cleavages (Fortini, 2002). In certain cases,stimulate N-Cad/CTF2 production suggesting that this
like E-cadherin, the -cleavage is greatly stimulated byreceptor regulates the -cleavage of N-cadherin. N-Cad/
calcium imbalance or apoptosis (Marambaud et al.,CTF2 binds the transcription factor CBP and promotes
2002). The -cleavage results in the release of solubleits proteasomal degradation, inhibiting CRE-depen-
cytosolic peptides containing the intracellular domainsdent transactivation. Thus, the PS1-dependent -cleav-
(ICDs) of the cleaved substrate proteins. Some of theseage product N-Cad/CTF2 functions as a potent repres-
peptides have been shown to migrate to the nucleussor of CBP/CREB-mediated transcription. Importantly,
where they may act as regulators of gene expressionPS1 mutations associated with familial AD (FAD) and
(Fortini, 2002). PS1 forms high-molecular weight com-a -secretase dominant-negative mutation inhibit
plexes with a number of proteins and its precise role inN-Cad/CTF2 production and upregulate CREB-medi-
the - and -cleavages of type I transmembrane proteinsated transcription indicating that FAD mutations cause
is under intense investigation (De Strooper, 2003).a gain of transcriptional function by inhibiting produc-
Transcriptional coactivator CBP (CREB binding pro-tion of transcriptional repressor N-Cad/CTF2. These
tein) interacts with and regulates the activities of a multi-
data raise the possibility that FAD mutation-induced
tude of signal-responsive transcription factors and may
transcriptional abnormalities maybe causally related thus integrate converging gene-regulatory pathways
to the dementia associated with FAD. (Goodman and Smolik, 2000). CBP acts as a scaffold
that facilitates recruitment of additional transcriptional
Introduction modulators on the basal transcriptional complex. In ad-
dition, CBP regulates many physiological processes in-
Presenilin1 (PS1) is a multipass transmembrane protein cluding cell growth, differentiation, and apoptosis.
involved in many cases of early-onset familial Alzhei- Changes in CBP activities are associated with a large
mer’s disease (FAD). Cellular PS1 is cleaved to yield number of developmental, neurodegenerative, and
N-terminal (PS1/NTF) and C-terminal (PS1/CTF) frag- mental retardation conditions, including the human Ru-
ments, which form stable 1:1 heterodimers that may benstein-Taybi syndrome, and overexpression of Dro-
represent the biologically active form of PS1 (Selkoe, sophila CPB can lead to neurodegeneration suggesting
2001). In cell cultures lacking adherens junctions, PS1 that cellular levels of CBP are tightly regulated (Good-
is mainly localized in the ER-Golgi system (Cupers et man and Smolik, 2000; Ludlam et al., 2002). CBP is a
al., 2001) but in cultures with extensive cell-cell contacts coactivator of transcription factor CREB (cyclic AMP
and in tissues, PS1 concentrates at the plasma mem- response element binding protein) that regulates the
brane where it binds cadherins and stabilizes the cadh- expression of a variety of genes that contain CREs (cy-
clic AMP response elements) in their promoters. CREB
is implicated in a number of cellular processes and dis-*Correspondence: nikos.robakis@mssm.edu
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Figure 1. A PS1-Mediated -Secretase Activity Cleaves N-Cadherin
(A) Extracts from PS1/ or PS1/ mouse embryos were probed on Western blots (WBs) either with anti-N-cadherin antibody C32 (upper
image) or anti-PS1/CTF antibody 33B10 (lower image). N-Cad/FL: full-length N-cadherin. Asterisk shows mouse IgGs.
(B) Extracts from PS1/ or PS1/ fibroblast cultures incubated for 16 hr in the absence or presence of DMSO, L-685,458 (0.5 M), or GM6001
(2.5 M) as indicated, were probed on WBs either with C32 or with 33B10 antibodies.
(C) Membranes (see Experimental Procedures) from PS1/ (lane 1) or PS1/ (lanes 2–4) fibroblasts or from N2a cell cultures (lanes 5 and 6)
incubated for 16 hr in the absence or presence of DMSO or L-685,458, were incubated at 37C for 2 hr, separated by centrifugation in a pellet
(P100, upper images) and a soluble (S100, lower images) fractions and then probed on WBs with C32 antibody.
(D) Membranes from HEK293 cell cultures stably transfected with vector alone (lanes 1 and 2), WT-PS1 (lanes 3–5), or D257A-PS1 (lanes 6
and 7) were incubated at 37C for 2 hr and then probed with either C32 (upper image), anti-PS1/NTF R222 (middle image) or 33B10 (lower
image) antibodies. Membranes from WT-PS1-transfected clone #7 were incubated in the absence () or presence () of L-685,458 (lanes 4
and 5). PS1/FL: full-length PS1. Results from two independent clones of each transfectant are shown.
eases (Mayr and Montminy, 2001) and CREB-dependent Results
gene expression is critical for the function and plasticity
A PS1-Mediated -Secretase Activityof the nervous system (Lonze and Ginty, 2002) including
Cleaves N-Cadherinlong-term memory and learning in both vertebrates and
PS1 knockout (PS1/) mouse embryos accumulatedinvertebrates (Kandel, 2001). Stimulation of CREB-medi-
a 40 kDa peptide (termed N-Cad/CTF1) detected withated transcription requires phosphorylation at CREB-
antibodies against the cytoplasmic sequence of N-cadh-Ser133, an event that leads to the recruitment of CBP
erin. This peptide was hardly detectable in wild-typeand stimulation of transcription (Arias et al., 1994;
(WT) mouse embryos although all embryos containedChrivia et al., 1993; Kwok et al., 1994). Here, we report
similar amounts of full-length N-cadherin (Figure 1A). Athat PS1 promotes an -cleavage of N-cadherin resulting
similar peptide accumulates in PS1/ fibroblasts or inin the production of a soluble ICD termed N-Cad/CTF2.
This peptide fragment binds CBP and promotes its deg- WT fibroblasts treated with the -secretase inhibitor
L-685,458 (Li et al., 2000), but not in control WT fibro-radation through the ubiquitin-proteasome system thus
decreasing nuclear CBP and suppressing CREB-medi- blasts (Figure 1B, lanes 1–4). Matrix metalloproteinase
(MMP) inhibitor GM6001 decreased N-Cad/CTF1 andated transcription. Importantly, PS1 FAD mutations in-
hibit N-Cad/CTF2 production causing a dysregulation increased full-length N-cadherin (Figure 1B, lanes 5 and
6). Together, these data suggest that N-Cad/CTF1 de-of CBP/CREB-dependent transcription.
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1–4). In contrast, no N-Cad/CTF2 was detected using
membranes prepared either from cells overexpressing
the -secretase dominant-negative PS1 mutant D257A
(Wolfe et al., 1999) (Figure 1D, lanes 6 and 7) or from
cells treated with L-685,458 (Figure 1D, lanes 4 and 5).
Together with the apparent SDS-PAGE molecular mass
of N-Cad/CTF2, these data indicate that N-cadherin un-
dergoes an -cleavage by the PS1/-secretase system
to release an ICD peptide of N-cadherin. Recent data
show that E-cadherin is processed by a similar mecha-
nism to release E-Cad/CTF2 (Marambaud et al., 2002).
Membrane Depolarization or NMDA Receptor
Agonists Stimulate the PS1/-Cleavage
of N-Cadherin
To examine whether the PS1/-secretase system is in-
volved in the processing of neuronal N-cadherin, we
tested membranes from a culture of primary neurons
prepared from brains of WT and PS1/mouse embryos.
Figure 2A (lanes 1 and 2) shows that N-cadherin frag-
ment N-Cad/CTF2 is detected in membranes from WT
cultures but not in membranes from PS1/ cultures.
Furthermore, N-Cad/CTF2 production is inhibited by
-secretase inhibitor L-685,458 (Figure 2A, lanes 3 and 4).
Ionomycin, an agent that stimulates calcium influx,
induces the PS1/-cleavage of E-cadherin (Marambaud
et al., 2002). Treatment of rat primary neuronal cultures
with this agent increased N-Cad/CTF2 suggesting that
calcium stimulates the PS1/-cleavage of N-cadherin
(data not shown). We then asked whether more specific
treatments that stimulate calcium influx through chan-
nels would also affect the -cleavage of N-cadherin.
Figure 2B (lanes 1 and 3) shows that treatment of rat
Figure 2. Membrane Depolarization or NMDA Receptor Agonists primary neuronal cultures with KCl stimulated produc-
Stimulate the PS1/-Cleavage of N-Cadherin in Primary Neurons
tion of peptide N-Cad/CTF2. Since high K depolarizes
(A) Membranes prepared from PS1/ (lane 1), PS1/ (lane 2) or
neuronal membranes resulting in neurotransmitter re-PS1/ (lanes 3 and 4) mouse brain neuronal cultures (see Experi-
lease at synaptic endings, we asked whether blockingmental Procedures) were incubated at 37C for 2 hr. Membranes
specific postsynaptic receptors would inhibit the in-from PS1/ neurons were incubated in the absence () or presence
() of L-685,458. Following incubation samples were probed with crease in N-Cad/CTF2. Figure 2B (lanes 1–4) shows that
either C32 (upper images) or R222 (lower image) antibodies. treatment of neurons with D()-2-amino-5-phosphono-
(B) Rat brain neurons were preincubated in the absence () or pres- valerate (D-APV), a specific antagonist of the NMDA
ence () of D-APV and then stimulated with either KCl, L-glutamate
receptor, completely inhibited the K-induced increase(L-Glu), or NMDA. Membranes from these neurons were used in in
in N-Cad/CTF2 (see also Figure 2C), suggesting thevitro assays for production of N-Cad/CTF2.
involvement of this receptor in the regulation of the PS1/(C) Densitometric quantitation of N-Cad/CTF2 production from two
independent experiments as in (B). Bars represent the mean  SE. -cleavage of N-cadherin. Indeed, direct stimulation of
the NMDA receptor using agonist L-glutamate also in-
duced an increase in N-Cad/CTF2 and this increase was
also blocked by D-APV (Figures 2B and 2C; lanes 1, 5,rives from full-length N-cadherin through a MMP cleav-
and 6). Application of NMDA had similar results (Figureage and is subsequently processed by a PS1-dependent
2B, lanes 1 and 7). The D-APV effects on N-Cad/CTF2-secretase-like activity.
production show that the stimulation-induced increaseA soluble 35 kDa peptide, termed N-Cad/CTF2, con-
of N-Cad/CTF2 is entirely NMDA receptor-dependent.taining the cytoplasmic sequence of N-cadherin is de-
In the absence of stimulation, an NMDA receptor-inde-tected by in vitro assays (see Experimental Procedures)
pendent (D-APV-unaffected) mechanism contributes tousing membrane fractions from either WT mouse fibro-
basal N-Cad/CTF2 production (Figures 2B and 2C). Ourblasts or from mouse neuroblastoma cell line N2a (Fig-
data indicate that the PS1/-cleavage of neuronalure 1C, lanes 2 and 5). N-Cad/CTF2 is greatly reduced
N-cadherin is stimulated by membrane depolarizationin the absence of the PS1 gene and is completely absent
and activation of the NMDA receptor.from cultures treated with L-685,458 (Figure 1C). The
residual N-Cad/CTF2 detected in PS1/ cells is proba-
bly due to PS2 activity, a PS1 homolog. Overexpression N-Cad/CTF2 Downregulates CREB-Mediated
Transcriptionof PS1 in HEK293 cells resulted in a significant stimula-
tion of N-Cad/CTF2 production compared to mem- Stimulation of synaptic NMDA receptor leads to activa-
tion of CREB-mediated gene expression (Lonze andbranes from vector-transfected cells (Figure 1D, lanes
Cell
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Figure 3. N-Cad/CTF2 Represses CREB-Mediated Transcription
(A) L cells were transfected with increasing amount of pN-Cad/CTF2 (N-Cad/CTF2) or with full-length N-cadherin expression vector (N-Cad/
FL) as indicated. CRE-dependent transactivation was measured in the absence () or presence () of cotransfected PKA (pFC-PKA) using CRE-
luciferase reporter plasmid (pCRE-Luc). CHOP-mediated transactivation was measured by cotransfection with the Gal4-fusion transactivator
plasmids (pFA-CHOP and pFR-Luc). Transfected cells were processed for luciferase activity (see Experimental Procedures). a and b: extracts
from transfected cells were probed on WBs with C32 antibody.
(B) Nuclear extracts from pN-Cad/CTF2-transfected L cells were incubated with biotinylated double-stranded DNA probes containing a binding
sequence for either CREB (left image) or MEF-1 (right image). Lanes 1 and 8: probes alone. Lanes 2 and 9: probe plus extract. Lanes 3 and
10: samples as in lanes 2 and 9 plus a 60-fold excess of unlabeled (cold) probes used as competitors. Lane 4: incubation was carried out in
the presence of antiphosphorylated CREB-Ser133 antibody 1B6. Lanes 5–7 and 11–13: nuclear extracts from cells transfected without (lanes
5 and 11) or with 0.2 g (lanes 6 and 12) and 0.5 g (lanes 7 and 13) of pN-Cad/CTF2 were incubated either with CREB (lanes 5–7) or MEF-1
(lanes 11–13) probes and then loaded on the gel. F indicates free probes. Note that shifted probes (S) were competed out with unlabeled
probes (lanes 3 and 10). CREB probe was supershifted (Ss) with antibody against phosphorylated CREB (lane 4).
(C) Semiquantitative RT-PCR was used to determine relative levels of c-fos or gapdh mRNAs from L cells transfected either with vector or
with 0.5 g of pN-Cad/CTF2. Graph represents the relative abundance of c-fos-specific PCR products following quantitation of the mRNA
signals shown in the upper image.
(D) Extracts from L cells transfected with increasing amount of pN-Cad/CTF2 were probed on WBs with anti-c-Fos (upper image), anti--tubulin
(middle image), or C32 (lower image) antibodies. Bars represent the relative amounts of c-Fos protein detected on WBs shown in the upper
image.
Ginty, 2002). To examine the functional consequences presses CRE-dependent transactivation. We used elec-
trophoretic mobility shift assays (EMSA) to examine theof increased N-Cad/CTF2 production, we first asked
whether this peptide affects CRE-dependent transacti- effects of N-Cad/CTF2 on CREB-DNA binding. Figure
3B (lanes 5–7) shows that nuclear extracts from N-Cad/vation, a process that relies on endogenous CREB. Fig-
ure 3A shows that transfection of N-cadherin-negative CTF2-transfected cells are defective in their ability to
promote formation of CREB/CRE-containing DNA com-L cells with N-Cad/CTF2 inhibits both constitutive and
PKA-stimulated CRE-dependent transactivation in a plexes. In contrast, N-Cad/CTF2 transfection had no
effect on complex formation between transcription fac-dose-dependent manner. Transactivation by CHOP-
response elements was not affected by N-Cad/CTF2 tor MEF-1 and a DNA probe containing MEF-1 binding
elements (Figure 3B, lanes 11–13). These data show that(Figure 3A) suggesting that this peptide specifically re-
N-Cadherin PS1/-Cleavage Regulates Transcription
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Figure 4. PS1 Inactivation Promotes CREB-
Mediated Transcription
(A) N2a cells cotransfected with plasmids
pCRE-luc and pFC-PKA were incubated for
16 hr with DMSO or with L-685,458 and CRE-
dependent transactivation was measured as
described above. Data are the mean  SE of
3 experiments normalized to -galactosidase
activity and protein concentration. *, P	 0.05
(Student’s t test).
(B) Total RNA isolated from N2a cells treated
either with DMSO or with L-685,458, was
analyzed by semiquantitative RT-PCR using
specific primers for c-fos and gapdh. Graph
represents the relative abundance of c-fos-
specific PCR products following quantitation
of the mRNA signals shown in the upper
image.
(C) Extracts from N2a cells treated either with
DMSO or with L-685,458, were probed on
WBs with anti-c-Fos or anti--tubulin anti-
bodies.
(D) Extracts from PS1/ or PS1/ mouse
fibroblasts were probed on WBs with either
anti-c-Fos or anti--tubulin antibodies.
(E) Extracts from PS1/ or PS1/ mouse
embryonic brains were probed on WBs with
anti-c-Fos (upper image), anti--tubulin (mid-
dle image), or 33B10 (lower image) anti-
bodies.
N-Cad/CTF2 decreases CREB binding to its cognate c-fos indicating that PS1 activity is needed for main-
taining normal expression of this gene.CRE motif.
To confirm that N-Cad/CTF2 suppresses CREB-
dependent transcription of endogenous genes, we N-Cad/CTF2 Binds CBP in the Cytoplasm
and Promotes Its Degradationasked whether the expression of c-fos mRNA and pro-
tein change in response to this peptide. c-fos promoter CREB-mediated transcription is stimulated by phos-
phorylation of CREB-Ser133 and CBP recruitment tocontains CREs and CREB is a strong regulator of the
transcription of this gene (Ahn et al., 1998). Figures 3C transcription initiation complexes formed at CRE-con-
taining promoters. We, however, failed to detect anyand 3D show that overexpression of N-Cad/CTF2 mark-
edly reduces the amounts of cellular c-fos mRNA and change of CREB phosphorylation in response to N-Cad/
CTF2 overexpression (Figure 5A, d). We then askedc-Fos protein but has no effect on the expression of
gapdh mRNA or on the levels of -tubulin suggesting whether this peptide might affect CREB-mediated tran-
scription by limiting the availability of CBP. Cell fraction-that N-Cad/CTF2 specifically inhibits c-fos expression.
We then asked whether conditions that inhibit both PS1 ation and biochemical studies showed that as expected,
in vector-transfected cells, CBP is found only in theactivity and N-Cad/CTF2 production, like L-685,458
treatment or absence of PS1, would affect CREB-medi- nuclear fraction where phosphorylated CREB is also
found (Figure 5A, lanes 1 and 3, a and d). Followingated transcription. Indeed, L-685,458 treatment of N2a
cells increased CRE-dependent transactivation (Figure transfection with N-Cad/CTF2, however, nuclear CBP
decreased with a concomitant increase in cytosolic4A) and stimulated c-fos mRNA (Figure 4B) and c-Fos
protein (Figure 4C) beyond the levels observed in un- CBP, indicating that in the presence of N-Cad/CTF2,
CBP translocates to the cytoplasm where N-Cad/CTF2treated controls, whereas gapdh mRNA and -tubulin
remained unchanged (Figures 4B and 4C). Furthermore, is localized (Figure 5A, a and b). In contrast to CBP,
N-Cad/CTF2 had no effects on the localization of phos-Figures 4D and 4E show that absence of PS1 results in
abnormally high levels of c-Fos protein in both fibroblast phorylated CREB, which remained in the nucleus (Figure
5A, d). Additional experiments showed that in N-Cad/cultures and mouse brain while levels of -tubulin re-
main unchanged. Together, our data show that down- CTF2-transfected cells, CBP coimmunoprecipitates with
N-Cad/CTF2 but not with -tubulin (Figure 5B). Theseregulation of PS1 activity results in a decreased produc-
tion of N-Cad/CTF2 and in a specific overexpression of data indicate that the two proteins form a complex in
Cell
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Figure 5. N-Cad/CTF2 Binds CBP in the Cytoplasm and Promotes Its Degradation
(A) L cells transfected either with vector (Vector) or pN-Cad/CTF2 (N-Cad/CTF2) were fractionated into nuclear and cytosolic fractions, and
probed on WBs with anti-CBP (a), anti-N-cadherin (b), anti--tubulin (c) or antiphosphorylated CREB (P-CREB; d) antibodies.
(B) Extracts from pN-Cad/CTF2-transfected L cells were immunoprecipitated either with nonimmune serum (NI) or with antibodies against
CBP (CBP), -tubulin (-Tub.), E-cadherin (C36), or N-cadherin (C32). Obtained IPs were probed with anti-CBP (upper image), anti-N-cadherin
(middle image), or anti--tubulin (lower image) antibodies. For reference, cell lysate was also probed (first lane).
(C) L cells transiently transfected with pN-Cad/CTF2 were analyzed by immunofluorescence staining. Cells were triple-labeled with DAPI
(blue), anti-CBP (red), and anti-N-cadherin (C32; green) antibodies. Arrows indicate pN-Cad/CTF2-transfected cells.
(D) HEK293 or L cells were transiently transfected either with vector or pN-Cad/CTF2. Cells were harvested at the indicated posttransfection
times (PT). Extracts were then probed on WBs with anti-CBP (upper images), anti--tubulin (middle images), and anti-N-cadherin (lower
images) antibodies.
(E) L cells transiently transfected with vector or pN-Cad/CTF2 for 30 hr were labeled with [35S]-methionine/cysteine for 30 min and then chased
for the indicated times. Cell extracts were immunoprecipitated in RIPA buffer with anti-CBP antibody and immunoprecipitates were analyzed
by SDS-PAGE and fluorography (upper image). Total extracts were also probed on WBs for N-Cad/CTF2 (lower image). Graph represents the
relative CBP levels following quantitation of labeled CBP shown in the upper image.
(F) L cells were transfected either with vector or pN-Cad/CTF2. Thirty hours after transfection, cells were incubated for 1 hr in the absence
() or presence () of 25 M of proteasome inhibitor ALLN and extracts were then immunoprecipitated with anti-CBP antibody. Ubiquitinated
CBP (Ub-CBP) was visualized on WBs using antiubiquitin antibody (upper image). Total extracts were also probed with C32 antibody (lower
image).
(G) L cells transiently transfected with vector or pN-Cad/CTF2 for 30 hr were incubated in the absence () or presence () of ALLN for an
additional 4 hr. Extracts were probed with anti-CBP (upper image) and C32 (lower image) antibodies.
(H) L cells were transfected with pN-Cad/CTF2 and with increasing amount of CBP expression vector as indicated. CRE-dependent transactiva-
tion was measured in the presence of cotransfected PKA using CRE-luciferase reporter plasmid. Data are the mean  SE of three experiments
normalized to -galactosidase activity and protein concentration.
N-Cadherin PS1/-Cleavage Regulates Transcription
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Figure 6. FAD-Linked PS1 Mutations Inhibit the -Cleavage of N-Cadherin and Increase CRE-Dependent Transactivation
(A and B) Membranes from two independent clones of HEK293 cells each stably transfected with vector alone, WT-PS1, or with PS1 mutants
M146L, A246E, E280A, 
E9, V82L, G384A, E280G, and Y115H were incubated in vitro and produced N-Cad/CTF2 was detected on WBs with
C32 (upper images). Numbers correspond to isolated clones. PS1 fragments from membrane extracts were detected with R222 (A, middle
image) or 33B10 (A and B, lower images).
(C) Combined densitometric quantitation of N-Cad/CTF2 production using two independent clones of each mutant (Figures 6A and 6B). N-Cad/
CTF2 levels were normalized to N-Cad/CTF2 produced from vector-transfected cells. Bars represent the mean  SE of three independent
experiments using two clones for each mutant.
(D) CRE-dependent transactivation was measured using two independent HEK293 cell stable clones of each mutant (Figures 6A and 6B). All
clones were cotransfected with pFC-PKA and pCRE-Luc. Luciferase activity data were normalized to -galactosidase activity and protein
concentration. Bars represent the mean  SE of three experiments. *, P 	 0.05; **, P 	 0.005; ***, P 	 0.001 (Student’s t test).
the cytoplasm. In agreement with the biochemical and 6 and 7). Together, our data show that N-Cad/CTF2
binds CBP and promotes its degradation thus downreg-immunoprecipitation studies, two-color immunofluores-
cence staining showed that compared to nontrans- ulating CREB-dependent transcription.
fected controls which display no CBP staining in the
cytoplasm, cells transfected with N-Cad/CTF2 show a PS1 FAD Mutants Do Not Stimulate N-Cad/CTF2
Production and Are Unable to Suppressclear cytoplasmic colocalization between N-Cad/CTF2
and CBP (Figure 5C). CREB-Mediated Transcription
To examine the effects of PS1 FAD mutations on theWe then asked whether N-Cad/CTF2 regulates CBP
turnover. Transfection of N-Cad/CTF2 in two cell lines -cleavage of N-cadherin, we measured the amounts of
N-cad/CTF2 produced in the in vitro assay using mem-reduces the steady-state levels of CBP (Figure 5D) and
pulse-chase analysis showed that exogenous N-Cad/ branes from HEK293 cells overexpressing comparable
levels of either WT PS1 or PS1 FAD mutants. FiguresCTF2 decreases the half-life of CBP (Figure 5E). These
data suggest that N-Cad/CTF2 promotes CBP degrada- 6A, 6B, and 6C show that membranes from HEK293 cell
cultures overexpressing WT PS1 produce approxi-tion. Since CBP is degraded by the proteasome (Lonard
et al., 2000), we asked whether N-Cad/CTF2 promotes mately seven times as much N-Cad/CTF2 as the vector-
transfected controls. In contrast, membranes fromCBP ubiquitination. Figure 5F shows that CBP ubiquiti-
nation increases in the presence of exogenous N-Cad/ HEK293 cell cultures each overexpressing a PS1 FAD
mutant carrying one of the missense mutations Y115H,CTF2 and that proteasome inhibitor ALLN prevents the
N-Cad/CTF2-induced CBP degradation (Figure 5G) sug- M146L, A246E, E280A, E280G, and G384A or the dele-
tion mutation 
E9, showed no increase in N-Cad/CTF2gesting that N-Cad/CTF2 promotes CBP degradation
by the ubiquitin-proteasome system. We then asked production indicating that these mutations are strong
inhibitors of the PS1-dependent -cleavage of N-cadh-whether increased CBP could overcome the inhibitory
effect of N-Cad/CTF2 on CRE-mediated transactivation. erin. PS1 FAD mutant V82L was the only mutant that
showed substantial -cleavage although it was less ac-Figure 5H shows that increased CBP expression res-
cued the N-Cad/CTF2-induced inhibition of CRE-medi- tive than the WT PS1 (Figures 6B and 6C).
That FAD mutations inhibit production of N-Cad/ated transactivation. Furthermore, CBP-stimulated
CRE-mediated transactivation was strongly inhibited by CTF2, a peptide that represses CREB-mediated tran-
scription, predicts that PS1 FAD mutants should be de-N-Cad/CTF2 (Figure 5H, compare bars 3 and 4 to bars
Cell
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fective in their ability to suppress CRE-dependent trans-
activation. Indeed, Figure 6D shows that although
overexpression of WT PS1 significantly suppressed
CRE-dependent transactivation, PS1 FAD mutants
Y115H, M146L, A246E, E280A, E280G, 
E9, and G384A
are unable to inhibit CRE-dependent transactivation. In-
terestingly, FAD mutants M146L, A246E, E280G, and
G384A, as well as the -secretase dominant-negative
mutant D257A, showed a clear dominant-positive effect
increasing CRE-dependent transactivation over that of
the vector control (Figure 6D). The inverse correlation
between the effects of PS1 mutants on N-Cad/CTF2
production and CRE-dependent transactivation ob-
served in all cases strongly supports the suggestion that
these mutants overstimulate transcription by inhibiting
production of N-Cad/CTF2.
To investigate the consequences of FAD mutations
in a physiologically more relevant system in the absence
of PS1 overexpression, we examined the -cleavage
of N-cadherin in two independent embryonic fibroblast
clones derived from a gene-targeted (knockin) mouse
homozygous for the human PS1 FAD mutation P264L
(Siman et al., 2000). Expression of the knockin mutant
PS1 allele is under the control of the endogenous PS1
gene. These models are distinct from overexpressing
transgenic models because the mutant gene is ex-
pressed at normal levels, similar to those observed in
WT models (Figure 7A, d). As controls, we used two
WT fibroblast cell lines independently derived from WT
littermates. Production of N-Cad/CTF2 from WT fibro- Figure 7. FAD-Linked PS1P264L Mutation Inhibits N-Cad/CTF2
Production and Increase Nuclear CBP and c-Fosblasts was sensitive to -secretase inhibitor L-685,458
(A) Membranes from embryonic fibroblast cultures isolated either(Figure 7A, c, lanes 1 and 2). Figure 7A (c, lanes 2–5)
from PS1P264L homozygous knockin mice (KI-3 and KI-1) or fromshows that samples from the knockin fibroblast cell lines
WT littermates (WT-3 and WT-2) were processed for the generationproduced undetectable amounts of N-Cad/CTF2 com-
of N-Cad/CTF2. Following incubation, membranes were probed with
pared to samples from the WT clones, indicating that this C32 (a–c) or 33B10 (d).
FAD mutation also inhibits the -cleavage of N-cadherin. (B) Nuclear preparations from either WT (WT-3 and WT-2) or
Furthermore, the PS1P264L knockin cells contained PS1P264L knockin (KI-3 and KI-1) fibroblasts were probed on WBs
with anti-CBP (upper image), anti-c-Fos (middle image), or anti-significantly higher levels of endogenous nuclear CBP
histone H3 (lower image) antibodies.and c-Fos compared to WT controls, although histone
(C) WT (WT-3) or PS1P264L knockin (KI-3) fibroblasts were incu-H3 levels remained unchanged (Figure 7B). We then
bated for 4 hr in the absence or presence of ALLN (25 M) or
asked whether by reducing N-Cad/CTF2 production, lactacystin (5 M). Nuclear extracts from these cells were probes
PS1P264L mutation inhibits the proteasomal degrada- on WBs with anti-CBP antibody.
tion of CBP. Figure 7C shows that, as expected, treat-
ment of WT fibroblasts with proteasomal inhibitors leads
to increased CBP levels. In contrast, no further CBP to affect the expression of many transcriptional systems
increase is observed in PS1P264L knockin fibroblasts, including CREB-dependent gene expression. Indeed,
suggesting that the proteasome-dependent degrada- overexpression of N-Cad/CTF2 inhibits CRE-dependent
tion of CBP is inhibited in these cells. Together, these transactivation, a CREB-mediated process, and causes
data indicate that by inhibiting N-Cad/CTF2, PS1 muta- a specific decrease in the expression of endogenous
tion P264L increases the nuclear levels of CBP and gene c-fos, the transcription of which is regulated by
c-Fos above those detected in normal controls sug- the CBP/CREB system (Ahn et al., 1998). In agreement
gesting that PS1 mutations may induce a transcriptional with an inhibitory function of the N-Cad/CTF2 peptide
dysregulation by inhibiting the PS1/-secretase activity. in CBP/CREB-mediated transcription, overexpression
of PS1 increases N-Cad/CTF2 production and sup-
presses CRE-dependent transactivation. In contrast,Discussion
conditions that inhibit N-Cad/CTF2 production result in
a specific increase in c-fos expression and CRE-depen-Our results show that N-cadherin is processed by the
PS1/-secretase system to produce ICD peptide N-Cad/ dent transactivation. Together, these data show that the
PS1-dependent peptide N-Cad/CTF2 binds CBP andCTF2 that complexes transcriptional coactivator CBP in
the cytoplasm and promotes its proteasomal degrada- promotes its degradation by the proteasome, thus act-
ing as a potent repressor of CBP/CREB-mediated tran-tion. CBP associates with and regulates the activity of a
large number of signal-responsive transcription factors. scription.
Following -cleavage of type I transmembrane pro-By promoting its degradation, N-Cad/CTF2 is predicted
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teins, several ICD peptides, including those derived from significant effects on A production either (A.T., unpub-
Notch1, APP, and CD44, have been shown to migrate lished data and Figure 1 in Murayama et al., 1999) thus
to the nucleus where they stimulate gene expression resembling a class of PS1 mutants linked to frontotem-
(Fortini, 2002). In contrast, the N-cadherin-derived ICD poral dementia that may show no increase in A (Amtul
fragment binds transcription factor CBP in the cyto- et al., 2002). Perhaps the toxicity of these mutants de-
plasm and promotes its proteasomal degradation sug- rives from interference with the production of other ICDs,
gesting a mechanism of PS1-mediated transcriptional some of which act as transcriptional regulators (see
repression. Thus, PS1 regulates surface to nucleus sig- Introduction).
naling and gene expression by controlling production c-Fos expression is increased in response to stress,
of peptides that may act either as transcriptional stimu- including A treatments, and it is believed that this pro-
lators or repressors. tein mediates proapoptotic signals during stress stimuli
Because CBP mediates activation of numerous tran- that lead to neuronal death (Gillardon et al., 1996; Jo-
scription factors it is not clear whether a particular tran- chum et al., 2001; Shaulian and Karin, 2002). Importantly,
scriptional pathway is preferably regulated by N-Cad/ c-Fos is increased in AD brains and it has been sug-
CTF2. Our data, however, show that this peptide down- gested that increased c-Fos expression plays important
shifts CREB-mediated gene expression, a system of roles in AD neuropathology and apoptosis (Anderson et
critical importance in neuronal development, survival, al., 1994; Marcus et al., 1998; Zhang et al., 1992). FAD
and synaptic function (Dawson and Ginty, 2002; Kandel, mutation-induced overexpression of c-fos may there-
2001). Depending on its localization, NMDA receptor fore increase neuronal vulnerability to environmental
stimulation may activate or inhibit CBP/CREB-depen- stresses and/or to endogenous toxic factors like A.
dent transcription (Hardingham et al., 2002). Our data Furthermore, because CBP regulates the expression of
that NMDA receptor activation increases production of a large number of genes, including genes important for
transcriptional repressor N-Cad/CTF2 suggests that the cell survival, FAD mutations might interfere with the ex-
PS1-dependent cleavage of neuronal N-cadherin may pression of a number of genes by inhibiting production
constitute an additional regulatory mechanism by which of N-Cad/CTF2.
NMDA receptor downshifts CBP/CREB-mediated tran- Transcriptional dysregulation has been recently impli-
scriptional activity. cated in the development of several polyglutamine-
Our data on the effects of PS1 FAD mutations on related disorders like Huntington’s disease (HD) and
N-Cad/CTF2 production and CRE-dependent transacti- dentatorubral-pallidoluysian atrophy (DRPLA); each
vation or c-Fos expression reveal a clear inverse rela- characterized by a specific pattern of neurodegenera-
tionship between N-Cad/CTF2 levels and CREB-depen- tion in the brain. It has been assumed that these dis-
dent transcription. Furthermore, these data suggest that eases are caused by abnormal aggregates of proteins
FAD mutations may cause a gain of transcriptional func- containing expanded polyglutamine stretches. Recent
tion by inhibiting the PS1-mediated -cleavage of N-cadh- work, however, suggests that transcriptional abnormali-
erin. This suggestion is further supported by data ob- ties, including interference with CBP- and CREB-depen-
tained in a physiologically relevant nonoverexpressing dent transcription, play key roles in the development of
FAD cell model showing that FAD mutant PS1P264L these neurodegenerative disorders (Freiman and Tjian,
inhibits production of N-Cad/CTF2 thus increasing both 2002).
nuclear CBP and c-Fos proteins to levels much higher In summary, we show that PS1 mediates production of
than those found in normal control cells. Therefore, FAD ICD N-Cad/CTF2, which promotes degradation of CBP,
mutations can cause transcriptional dysregulation by suppressing transcription. FAD mutants inhibit N-Cad/
inhibiting production of transcriptional repressor N-Cad/ CTF2 production and overstimulate transcription indi-
CTF2. cating that a primary effect of these mutations is a loss
Our data that PS1 activity is needed for maintaining
of PS1/-cleavage function. Stimulation of the -cleav-
normal expression of endogenous genes like c-fos and
age of N-cadherin and/or of N-Cad/CTF2 production
that by inhibiting N-Cad/CTF2 production PS1 FAD mu-
may offer opportunities for the development of new ther-tations overstimulate CRE-dependent transactivation,
apeutics in AD.raise the possibility that FAD mutation-induced tran-
scriptional abnormalities are causally related to the de- Experimental Procedures
mentia associated with FAD. Although it is presently
unclear how overstimulation of CBP activity may lead to Materials and Antibodies
L-685,458, ALLN, and lactacystin were obtained from Calbiochem;neurodegeneration in AD, cellular CBP activity is tightly
GM6001 from Chemicon; D-APV, L-glutamate, and NMDA fromregulated and abnormalities in the expression of CBP
Sigma. Rabbit polyclonal antiserum R222 against PS1/NTF andresult in a large number of developmental defects
mouse monoclonal antibody 33B10 specific for PS1/CTF were pre-
(Goodman and Smolik, 2000). Moreover, high CBP activ- pared as described (Georgakopoulos et al., 1999). Anti-N-cadherin
ity has been linked to neurodegeneration in Drosophila (C32) and anti-E-cadherin (C36) antibodies were from BD Transduc-
(Ludlam et al., 2002). These observations indicate that tion Laboratories. Anti--tubulin, anti-CBP (A-22), anti-c-Fos, and
anti-ubiquitin (P4D1) were from Santa Cruz Biotechnology. Antibodydysregulation of CBP activity can cause severe cellular
against phosphorylated CREB at Ser133 (1B6) were from Cell Signal-damage and provide support for the hypothesis that
ing Technology. Anti-Histone H3 antibody was from Upstate Bio-FAD mutations may contribute to AD neuropathology by
technology.inhibiting N-Cad/CTF2 production and overstimulating
CBP activity. The exception of mutation V82L that Cell Lines, Cell Culture, and Transfections
showed only a weak inhibition of the PS1/-cleavage of N2a, HEK293, L cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) plus 10% fetal bovine serum (FBS), penicillin, andN-cadherin may be of interest. This mutation has no
Cell
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streptomycin in 5% CO2 at 37C. Embryonic fibroblasts from protein aliquot from the nuclear and cytosolic fractions was analyzed
on WBs.PS1P264L homozygous knockin mice were prepared as described
(Siman et al., 2001). HEK293 cell lines stably transfected either with
WT or mutant PS1 cDNAs cloned into pCI-neo expression vector Reverse Transcriptase (RT)-PCR Analysis
were grown in the presence of G418. L cells were transfected with Total RNA was extracted from cells using an RNeasy Mini Kit (Qia-
chicken cytoplasmic domain of N-cadherin (N-Cad/CTF2) inserted gen) according to instructions by the manufacturer. Analysis of gene
into vector pECE (pN-Cad/CTF2) or with full-length mouse CBP expression was performed using semiquantitative RT-PCR. The fol-
inserted into vector pRc/RSV. lowing primers were used: 5-GGGTTTCAACGCCGACTACG-3 and
5-CAGCTTGGGAAGGAGTCAGC-3 for c-fos; 5-TGTCGTGGAGT
CTACTGG-3 and 5-CAGCATCAAAGGTGGAGG-3 for gapdh.Immunoprecipitations (IPs), Immunoblotting,
and Immunofluorescence
Electrophoretic Mobility Shift Assay (EMSA)IPs were performed as described (Marambaud et al., 2002) in 4C
Nuclear extracts from CBP-transfected L cells were prepared usingHEPES buffer (25 mM HEPES, [pH 7.4], 150 mM NaCl, 1 complete
the extraction kit N-XTRACT (Sigma) according to manufacturer’sprotease inhibitor cocktail, Roche) containing 0.5% Nonidet P40
instructions. Ten micrograms of nuclear extracts were used for(NP-40). For Western blot (WB) analysis, cells were solubilized in
EMSA performed according to manufacturer’s instructions using4C RIPA buffer as described (Marambaud et al., 2002). Immunofluo-
biotinylated double-stranded oligonucleotide probes containingrescence was performed as described (Georgakopoulos et al., 1999)
DNA binding motifs for CREB or MEF-1 (Panomics). Probes are aswith the following modifications: to visualize nuclei, cells were
follows: CREB, 5-AGAGATTGCCTGACGTCAGAGAGCTAG-3; MEF-1,treated for 5 min with 4,6-diamidino-2-phenylindole (DAPI, 1:5000;
5-GATCCCCCCAACACCTGCTGCCTGA-3. Reaction products wereSigma). Fluorescence microscopy and digital image acquisition
separated on 6% polyacrylamide gels in cold TBE buffer (50 mMwere carried out using an Axioskop2 microscope (Zeiss).
Tris-HCl, 45 mM Boric acid, and 0.5 mM EDTA), transferred to nylon
membranes (Immobilon-Ny, Millipore) and bound probes were im-Mouse Embryo Preparation and Primary Neuronal Cultures
mobilized for 30 min at 85C and visualized by chemiluminescencePS1/, / or / mouse embryos were collected at E18.5 and all
using streptavidin-HRP conjugate. For antibody supershift analysis,bodies or brains were solubilized in RIPA buffer as described (Baki
nuclear extract was incubated for 3 hr at 4C with 2 l of 1B6et al., 2001). Fifty micrograms of extracts were analyzed on WBs.
antibody prior to probe addition.Mixed hippocampal and cortical neuronal cultures were prepared
from E18 mouse or rat brains as described (Banker and Goslin,
Metabolic Labeling1991). Neurons were maintained ten days in vitro in glial conditioned
Thirty hours after transfection, L cells were starved for 30 min inMEM containing 2% glucose and N2 supplements (Bottenstein and
methionine/cysteine-free DMEM plus 10% dialyzed FBS in 5% CO2Sato, 1979) and then were stimulated for 15 min with Mg2-free
at 37C, and were metabolically labeled for 30 min with 150 Ci/mlHanks’ balanced salt solution (HBSS, Sigma) containing KCl (50
of [35S]-methionine/cysteine (EXPRE35S35S, PerkinElmer). Cells weremM), L-glutamate (50 M), or NMDA (50 M). D-APV (100 M) was
then washed twice with PBS and chased for the indicated times inapplied 15 min before stimulation.
DMEM plus 10% FBS and 2 mM of cold methionine and cysteine.
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